Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,468 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients.
Bellocchi MC, Aragri M, Carioti L, Fabeni L, Pipitone RM, Brancaccio G, Sorbo MC, Barbaliscia S, Di Maio VC, Bronte F, Grimaudo S, Mazzucco W, Frigeri F, Cantone M, Pinto A, Perno CF, Craxì A, Gaeta GB, Di Marco V, Ceccherini-Silberstein F. Bellocchi MC, et al. Among authors: pinto a. Cells. 2019 Jul 2;8(7):666. doi: 10.3390/cells8070666. Cells. 2019. PMID: 31269695 Free PMC article.
Aging and the hemopoietic system.
Pinto A, De Filippi R, Frigeri F, Corazzelli G, Normanno N. Pinto A, et al. Crit Rev Oncol Hematol. 2003 Oct 15;48(Suppl):S3-S12. doi: 10.1016/j.critrevonc.2003.06.006. Crit Rev Oncol Hematol. 2003. PMID: 14563515 Review.
Treatment of Acute Hepatitis C With Ledipasvir and Sofosbuvir in Patients With Hematological Malignancies Allows Early Re-start of Chemotherapy.
Brancaccio G, Sorbo MC, Frigeri F, Rizzo V, Cantone M, Genderini F, Fabeni L, Pinto A, Perno CF, Ceccherini-Silberstein F, Gaeta GB. Brancaccio G, et al. Among authors: pinto a. Clin Gastroenterol Hepatol. 2018 Jun;16(6):977-978. doi: 10.1016/j.cgh.2017.10.032. Epub 2017 Nov 28. Clin Gastroenterol Hepatol. 2018. PMID: 29104131 No abstract available.
Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma.
Corazzelli G, Capobianco G, Arcamone M, Ballerini PF, Iannitto E, Russo F, Frigeri F, Becchimanzi C, Marcacci G, De Chiara A, Pinto A. Corazzelli G, et al. Among authors: pinto a. Cancer Chemother Pharmacol. 2009 Oct;64(5):907-16. doi: 10.1007/s00280-009-0941-9. Epub 2009 Feb 15. Cancer Chemother Pharmacol. 2009. PMID: 19219604
4,468 results